SecProbe.io - Filing

CORRESP Filing

Tonix Pharmaceuticals Holding Corp.
Date: Sept. 3, 2025 · CIK: 0001430306 · Accession: 0001999371-25-012501

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-287965

Date

June 12, 2025

Author

yours

Form

CORRESP

Company

Tonix Pharmaceuticals Holding Corp.

Letter

Tonix Pharmaceuticals Holding Corp.

Main Street, Suite 101

Chatham, New Jersey 07928

September 3, 2025

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Re: Tonix Pharmaceuticals Holding Corp.

Registration Statement on Form S-3 (File No. 333-287965)

Filed on June 12, 2025

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, Tonix Pharmaceuticals Holding Corp. hereby requests that the above-referenced Registration Statement (the " Registration Statement ") be declared effective by the Securities and Exchange Commission at 4:30 p.m., Eastern Time, on September 4, 2025, or as soon as practicable thereafter.

Please call Irina Ishak of Lowenstein Sandler LLP at (973) 422-6406 to confirm the effectiveness of the Registration Statement or with any questions.

Very truly
yours,
TONIX PHARMACEUTICALS HOLDINGS CORP.

Show Raw Text

CORRESP
 1
 filename1.htm

 Tonix
Pharmaceuticals Holding Corp.

 26
Main Street, Suite 101

 Chatham,
New Jersey 07928

 September
3, 2025

 VIA
EDGAR

 United
States Securities and Exchange Commission

 Division
of Corporation Finance

 100
F Street, N.E.

 Washington,
D.C. 20549

 Re:
 Tonix
 Pharmaceuticals Holding Corp.

 Registration
 Statement on Form S-3 (File No. 333-287965)

 Filed
 on June 12, 2025

 Ladies
and Gentlemen:

 In
accordance with Rule 461 under the Securities Act of 1933, as amended, Tonix Pharmaceuticals Holding Corp. hereby requests that the above-referenced
Registration Statement (the " Registration Statement ") be declared effective by the Securities and Exchange Commission
at 4:30 p.m., Eastern Time, on September 4, 2025, or as soon as practicable thereafter.

 Please
call Irina Ishak of Lowenstein Sandler LLP at (973) 422-6406 to confirm the effectiveness of the Registration Statement or with any questions.

 Very truly
 yours,

 TONIX PHARMACEUTICALS HOLDINGS CORP.

 By:
 /s/
 Bradley Saenger

 Name:
 Bradley Saenger

 Title:
 Chief Financial Officer